Correction to: Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)

被引：0
|
作者：
Taylor M. Patek
Chengwen Teng
Kaitlin E. Kennedy
Carlos A. Alvarez
Christopher R. Frei
机构：
[1] The University of Texas at Austin,Pharmacotherapy Division, College of Pharmacy
[2] The University of Texas Health Science Center at San Antonio,Pharmacotherapy Education and Research Center, Long School of Medicine
[3] Texas Tech University Health Sciences Center,Division of Clinical/Translational Research, Hodge School of Pharmacy
[4] South Texas Veterans Health Care System,undefined
[5] University Health System,undefined
来源：
Drug Safety | 2020年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the original publication of the article, the second sentence in the figure 2 caption should read as below:
引用
下载
收藏
页码：825 / 825
相关论文
共 50 条
  • [21] Pharmacovigilance study of the association between progestogen and depression based on the FDA adverse event reporting System (FAERS)
    Hui Gao
    Xiaohan Zhai
    Yan Hu
    Hang Wu
    Scientific Reports, 15 (1)
  • [22] A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib
    Zhang, Xusheng
    Ren, Xiuli
    Zhu, Tianyu
    Zheng, Wanjin
    Shen, Chengwu
    Lu, Cuicui
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [23] A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax
    Yang, Yang
    Shu, Yamin
    Chen, Guosong
    Yin, Yanchao
    Li, Feie
    Li, Juan
    PLOS ONE, 2022, 17 (12):
  • [24] Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
    Zhu, Jinfeng
    Hu, Mianda
    Liang, Yingshi
    Zhong, Mingjun
    Chen, Zilin
    Wang, Zhenjie
    Yang, Yujia
    Luo, Ziyi
    Zeng, Wenqi
    Li, Jiahui
    Du, Yikuan
    Liu, Yi
    Yang, Chun
    HELIYON, 2024, 10 (14)
  • [25] Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database
    Zhou, Jianxing
    Wei, Zipeng
    Xu, Baohua
    Liu, Maobai
    Xu, Ruichao
    Wu, Xuemei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] A real-world pharmacovigilance study of polatuzumab vedotin based on the FDA adverse event reporting system (FAERS)
    Liu, Dan
    Mao, Wei
    Hu, Bin
    Li, Xingxing
    Zhao, Quanfeng
    Zhang, Lin
    Hu, Jing
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Melasma secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS)
    Yaxin Qu
    Shuxin Wang
    Hanzhang Xie
    Xiao Meng
    Bingnan Cui
    Zhanshuo Xiao
    BMC Pharmacology and Toxicology, 26 (1)
  • [28] Catatonia related to tacrolimus: a real world pharmacovigilance study of FDA adverse event reporting system (FAERS) database
    Yang, Jing
    Yang, Hui
    An, Zhuoling
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [29] Evaluating Reports of Pancreatic Malignancy and Liraglutide: A Pharmacovigilance Study of the FDA Adverse Event Reporting System
    Alvarez, Carlos A.
    Teng, Chengwen
    Mansi, Ishak
    DIABETES, 2020, 69
  • [30] Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
    Ma, Pan
    Pan, Xinmei
    Liu, Ruixiang
    Qu, Ya
    Xie, Linli
    Xie, Jiangchuan
    Cao, Liya
    Chen, Yongchuan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
12345